MARKET

LTRN

LTRN

Lantern Pharma Inc
NASDAQ
3.660
-0.230
-5.91%
After Hours: 3.660 0 0.00% 16:05 03/07 EST
OPEN
3.800
PREV CLOSE
3.890
HIGH
3.910
LOW
3.560
VOLUME
27.31K
TURNOVER
--
52 WEEK HIGH
11.99
52 WEEK LOW
2.790
MARKET CAP
39.47M
P/E (TTM)
-2.0634
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LTRN last week (0224-0228)?
Weekly Report · 4d ago
Weekly Report: what happened at LTRN last week (0217-0221)?
Weekly Report · 02/24 11:43
Weekly Report: what happened at LTRN last week (0210-0214)?
Weekly Report · 02/17 11:40
Weekly Report: what happened at LTRN last week (0203-0207)?
Weekly Report · 02/10 11:32
Weekly Report: what happened at LTRN last week (0127-0131)?
Weekly Report · 02/03 11:38
Biotech Alert: Searches spiking for these stocks today
TipRanks · 01/27 16:10
Lantern Pharma Advances Cancer Therapies With RADR Platform and Global ADC Collaborations
Benzinga · 01/27 12:58
LANTERN PHARMA : ANNOUNCES ADVANCEMENTS IN APPLICATION OF CO'S RADR AI PLATFORM TO ACCELERATE DEVELOPMENT OF ANTIBODY-DRUG CONJUGATES FOR CANCER
Reuters · 01/27 12:57
More
About LTRN
More
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform with multiple clinical-stage drug programs. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 60 billion oncology-focused data points and a library of over 200 advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.
Recently
Symbol
Price
%Change

Webull offers Lantern Pharma Inc stock information, including NASDAQ: LTRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LTRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LTRN stock methods without spending real money on the virtual paper trading platform.